Page last updated: 2024-11-11

propenylphosphonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-(2-propargyloxyphenyl)hexanoic acid: inhibits rat renal microsomal arachidonic acid epoxidation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

propenylphosphonic acid: RN given is for (Z) isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID53741002
CHEBI ID197020
MeSH IDM0201740
PubMed CID6436667
SCHEMBL ID462085
MeSH IDM0201740

Synonyms (45)

Synonym
CHEBI:197020
6-(2-prop-2-ynoxyphenyl)hexanoic acid
ppoh
6-(2-propargyloxyphenyl)hexanoic acid
206052-01-9
AKOS025294863
HMS3649G22
DTXSID40706337
6-{2-[(prop-2-yn-1-yl)oxy]phenyl}hexanoic acid
6-(2-propargyloxyphenyl)hexanoic acid, >=98%, solid
J-013457
SR-01000946611-1
sr-01000946611
benzenehexanoic acid, 2-(2-propyn-1-yloxy)-
MS-23494
2-(2-propyn-1-yloxy)-; 6-{2-[(prop-2-yn-1-yl)oxy]phenyl}hexanoic acid
u3t ,
6-[2-(prop-2-yn-1-yloxy)phenyl]hexanoic acid
HY-119647
CS-0077200
6-(2-(prop-2-yn-1-yloxy)phenyl)hexanoic acid
[(z)-prop-1-enyl]-phosphonic acid
25383-06-6
propenylphosphonic acid
[(z)-prop-1-enyl]phosphonic acid
einecs 246-928-1
ec 246-928-1
cis-propenylphosphonic acid
AKOS016010975
(z)-prop-1-en-1-ylphosphonic acid
XWCIXXXLOAAWPU-IHWYPQMZSA-N
SCHEMBL462085
W-110629
(z)prop-1-en-1-ylphosphonic acid
((z)-propenyl)-phosphonic acid
A919298
p-(1z)-1-propen-1-ylphosphonic acid
DTXSID801293064
(z)-prop-1-en-1-ylphosphonicacid
P6Z7P82J2L
phosphonic acid, propenyl-, (z)-
(cis-1-propenyl)phosphonic acid
phosphonic acid, p-(1z)-1-propen-1-yl-
[(z)-1-propenyl]phosphonic acid
propenylphosphonic acid, cis-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (17.65)18.2507
2000's11 (64.71)29.6817
2010's3 (17.65)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.99 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]